DIA Europe 2019 has ended
avatar for Gaby Danan

Gaby Danan

Pharmacovigilance Expert
Gaby Danan, MD, PhD, was the EU Qualified Person for Pharmacovigilance for Sanofi until his 2010 retirement. He has served on the Council for International Organizations of Medical Sciences and International Council on Harmonisation Expert Working Groups, especially as the European Federation of Pharmaceutical Industries and Associations Clinical Safety E2B topic leader, and co-chaired the EudraVigilance Expert Working Group from its inception until 2009. Dr. Danan co-published the Roussel Uclaf Causality Assessment Method for drug-induced liver injury, has authored papers on pharmacovigilance definitions and methodologies, chaired the DIA 2010 Annual Meeting, and serves on the DIA Content Committee for Europe, Middle East, and Africa.

My Speakers Sessions

Wednesday, February 6

15:15 CET

Thursday, February 7

15:15 CET